Notice of first launch, interruption or termination of supply of a human drug
 DateHolder ▼CodeDrugDate fromSubject
 9.6.2022AbbVie Deutschland GmbH & Co. KG (ABV-DE)47592LUMIGAN 0,3 mg/ml očná roztoková instilácia (int opo 1x3 ml/0,9 mg (fľ.LDPE))8.6.2022R
 5.1.2024AbbVie Deutschland GmbH & Co. KG (ABV-DE)2193CVenclyxto 100 mg filmom obalené tablety (tbl flm 14 (7x2)x100 mg (blis.PVC/PE/PCTFE/Al-jednotl.dávka))1.3.2024Z
 14.6.2022AbbVie Deutschland GmbH & Co. KG (ABV-DE)47592LUMIGAN 0,3 mg/ml očná roztoková instilácia (int opo 1x3 ml/0,9 mg (fľ.LDPE))14.6.2022O
 22.3.2023AbbVie Deutschland GmbH & Co. KG (ABV-DE)35456GANFORT 0,3 mg/ml + 5 mg/ml očná roztoková instilácia (int opo 1x3 ml (fľ.LDPE))23.3.2023O
 27.1.2022AbbVie Deutschland GmbH & Co. KG (ABV-DE)87018Norvir 100 mg filmom obalené tablety (tbl flm 30x100 mg (fľa.HDPE))1.4.2022Z
 24.1.2025AbbVie s.r.o. (ABV)3366EDuodopa SC 240 mg/ml + 12 mg/ml infúzny roztok (sol inf 7x10 ml (liek.inj.skl.))27.1.2025U
 15.11.2023AbbVie s.r.o. (ABV)1534CBELKYRA 10 mg/ml (sol inj 4x2 ml/20 mg (liek.inj.skl.))15.1.2024Z
 10.1.2020AbbVie s.r.o. (ABV)46784Zemplar 1 mikrogram mäkké kapsuly (cps mol 28x1 µg (blis.PVC/fluóropolymér/Al))10.1.2020O
 20.12.2019AbbVie s.r.o. (ABV)46784Zemplar 1 mikrogram mäkké kapsuly (cps mol 28x1 µg (blis.PVC/fluóropolymér/Al))12.12.2019R
 14.8.2020AbbVie s.r.o. (ABV)34992CHIROCAINE 5 mg/ml (sol ijf 10x10 ml (amp.PP))14.8.2020Z
 29.7.2021AbbVie s.r.o. (ABV)1534CBELKYRA 10 mg/ml (sol inj 4x2 ml/20 mg (liek.inj.skl.))29.7.2021R
 30.1.2023Ablynx NV (ABY)8964CCablivi 10 mg prášok a rozpúšťadlo na injekčný roztok (plv iol iol 1x10 mg + 1x1 ml solv. (liek.inj.skl. + striek.inj.napl.skl.))10.12.2022U
 19.11.2019Accord Healthcare Polska Sp. z o.o. (AOK)5715ACytarabine Accord 100 mg/ml injekčný a infúzny roztok (sol ijf 1x1 ml (liek.inj.skl.))14.11.2019O
 30.7.2019Accord Healthcare Polska Sp. z o.o. (AOK)4516CClozapine Accord 100 mg tablety (tablety 50x100 mg (blis.Al/PVC/PVDC))17.7.2019O
 19.11.2019Accord Healthcare Polska Sp. z o.o. (AOK)05194Fluorouracil Accord 50 mg/ml injekčný a infúzny roztok (sol ijf 1x100 ml/5 g (liek.inj.skl.))19.11.2019R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)